“…Dermal bioavailability review papers (n=18) appear in the literature from 2004 and cover the various aspects of dermal exposure assessment methods (Moody and Maibach, 2006;Van De Sandt et al, 2007;Frasch et al, 2014), compound group reviews (pesticides and organic flame retardants) (Tripp et al, 2007;Abdallah et al, 2015), metabolic pathways (Pannatier et al, 1978), contaminants in soil (Spalt et al,, 2009;Andersen et al, 2014), and in silico modelling (Moss et al,, 2002a;Cronin and Schultz, 2003;Degim, 2006;Anissimov et al,, 2013;Anissimov, 2014;Couto et al,, 2014 Whilst this review is primarily aimed at in vitro testing methodologies for dermal bioavailability it is important to give an overview of the in vivo approaches as these supply data from physiologically and metabolically intact systems and are considered the "gold standard", from which base in vitro tests can be developed and compared. In vivo studies are, however, associated with strong ethical issues and there is an increasing movement towards the reduction of the use of animal testing e.g.…”